Tailor Made for cash-pay clinics: how the economics work

Landed cost in a cash-pay clinic is the per-vial drug cost plus shipping and any processing fees. Tailor Made sets pricing through clinic agreements after account approval, so the clinic confirms the all-in number during onboarding rather than browsing a public catalog. The practical questions are what the per-vial rate is on your top peptide and hormone SKUs, how ship-to-patient versus ship-to-clinic affects total cost, and whether agreement pricing holds across refill cycles.

For a cash-pay model, predictability matters as much as the headline rate. Agreement pricing that shifts, or costs that are not visible per order in the EMR portal, makes it hard to set a stable patient price. The economic evaluation of Tailor Made is less about whether integrative compounders are competitive and more about how clearly and consistently all-in landed cost is surfaced before and after you quote patients.

Fizy Health takes a pass-through approach built for cash-pay margin when clinics use more than one 503A partner. It shows resolved per-vial 503A cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment — so the owner sets patient prices on the same number the clinic will actually pay, and the prescriber can quote at the visit on live cost. There is no per-vial markup layer hidden inside a negotiated agreement; the drug cost passes through and the platform fee is stated.

On the operations side, one clinic cart batches the refill day and cart validation catches invalid SIGs, prescriber state mismatches, and stock gaps before payment, so the clinic stops paying for orders that get rejected after checkout. For a cash-pay clinic ordering across multiple compounders, the combined effect is margin you can see before you order and fewer surprises that quietly erode the spread.